Non-Invasive Method for Quantitative Evaluation of Exogenous Compound Deposition on Skin  by Stamatas, Georgios N. et al.
Non-Invasive Method for Quantitative Evaluation of
Exogenous Compound Deposition on Skin
Georgios N. Stamatas, Jeff Wu, and Nikiforos Kollias
Johnson & Johnson Consumer Products Worldwide, Skillman, New Jersey, U.S.A.
Topical application of active compounds on skin is
common to both pharmaceutical and cosmetic
industries. Quanti®cation of the concentration of a
compound deposited on the skin is important in
determining the optimum formulation to deliver the
pharmaceutical or cosmetic bene®t. The most com-
monly used techniques to date are either invasive or
not easily reproducible. In this study, we have devel-
oped a noninvasive alternative to these techniques
based on spectro¯uorimetry. A mathematical model
based on diffusion approximation theory is utilized
to correct ¯uorescence measurements for the attenu-
ation caused by endogenous skin chromophore
absorption. The limitation is that the compound of
interest has to be either ¯uorescent itself or ¯uores-
cently labeled. We used the method to detect topic-
ally applied salicylic acid. Based on the mathematical
model a calibration curve was constructed that is
independent of endogenous chromophore concentra-
tion. We utilized the method to localize salicylic acid
in epidermis and to follow its dynamics over a per-
iod of 3 d. Key words: ¯uorescence spectroscopy/salicylic
acid/optical modelling. J Invest Dermatol 118:295±302,
2002
S
imple, fast, and noninvasive in vivo methods for estimating
exogenous compound deposition on skin are invaluable
tools in understanding the pharmacokinetics of topical
formulations. In order to quantify the deposition of a
substance externally applied on skin several techniques
have been developed. Of those the most commonly used to date
are invasive (biopsy, microdialysis) or minimally invasive (Benfeldt,
1999). Tape stripping is a minimally invasive method based on the
removal of stratum corneum layers by successive tape applications
and removals and the subsequent analysis of the removed material
on the tape strips for drug content. Tape stripping followed by
solvent extraction and high performance liquid chromatography
(HPLC) has been used by many investigators (Pirola et al, 1998;
Schwarb et al, 1999; Tsai et al, 1999). Another variation of this
method is to use a radiolabeled equivalent of the compound to be
deposited and measure the radiation on the tape strips by liquid
scintillation methods (Bommannan et al, 1992; Wester et al, 1998).
Such radiolabeling methods have been reported to be expensive
and time consuming (Schaefer and Redelmeier, 1996). Tape
stripping methods appear to have many limitations, such as the
inability to provide serial sampling from the same site.
Furthermore, the quantity of corneocytes removed is not linearly
proportional to the number of tape strips (Weigmann et al, 1999).
Several factors can in¯uence the quantity of stratum corneum
removed by each piece of tape, e.g., the removing force and
manner, the hydration of skin, anatomical site, and interindividual
variation (Marttin et al, 1996). Finally, the removal of corneocyte
layers can be incomplete due to the presence of microscopic groove
structures (van der Molen et al, 1997) also known as microrelief.
In vivo ¯uorescence spectroscopy has been proposed as a
noninvasive alternative for the assessment of deposition or pene-
tration of substances into the skin (Sennhenn et al, 1993; Rhodes
and Diffey, 1997; Wagnieres et al, 1998). These reports have not
taken into consideration phenomena of photon reabsorption and
scattering in the tissue, however, and therefore such measurements
may vary a lot between people of different skin types and between
different anatomical sites of the same individual. Absorption and
scattering corrections of ¯uorescence signals have been developed
for studies of native skin ¯uorescence (Wu et al, 1993; Zeng et al,
1995).
Salicylic acid is widely used in topical preparations to remove
excess scales in the treatment of hyperkeratotic conditions, such as
psoriasis and seborrheic dermatitis. When added to cosmetic
formulations, it can increase cell renewal and boost the anti-
microbial capabilities of the formulation. Due to its keratolytic
properties salicylic acid is present in a wide range of wart and callus
remedies as well as in antidandruff shampoos. Its ¯uorescence
properties allow for its detection as an impurity in solid formula-
tions of acetyl-salicylic acid (Schenk et al, 1972; Street and Schenk,
1981). Neubert et al (1990) have used the tape stripping technique
combined with ¯uorescence spectroscopy of the extracted solution
to measure salicylic acid deposition on skin.
The goal of this investigation was to evaluate the feasibility of
quantifying noninvasively in vivo the concentration of topical
deposition of a model ¯uorescing compound (salicylic acid) on
human skin independent of anatomical location and interindividual
differences in skin color. To this end we developed a method based
on ¯uorescence spectroscopy with corrections for photon reab-
sorption and scattering by the skin tissue.
MATERIALS AND METHODS
Volunteers and application method In all experiments 10 ml of each
solution were applied evenly on predetermined circular areas (2.9 cm
diameter) on the volar forearm of each volunteer.
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In the ®rst set of experiments a series of dilutions of an aqueous
formulation containing salicylic acid (3% wt/vol initial concentration)
were applied to the forearms of 10 healthy volunteers (ages 20±50 y).
The surface concentrations of salicylic acid applied ranged between 1 and
25 mg per cm2. Measurements were acquired from treated skin sites after
solvent evaporation, as well as from adjacently located untreated and
placebo-treated sites. All sites of measurement were free of skin diseases,
uneven skin tones, sunburn, tattoos, and scars.
In another set of experiments a salicylic acid solution (initial surface
concentration of salicylic acid was 3 mg per cm2) was applied on both
volar forearms of two volunteers (a total of four sites). Square pieces
(2.5 cm 3 2.5 cm) of adhesive tape (#5413, 3M, St. Paul, MN) were
applied gently on the treated sites. The tapes were stripped after 1 min.
A total of 20 tapes were applied sequentially. Fluorescence measurements
were acquired before and after salicylic acid application as well as after
each tape strip.
In a third set of experiments we followed salicylic-acid-induced
¯uorescence over time. Two solutions (10 ml each) of different salicylic
acid concentrations (3 mg per cm2 and 10 mg per cm2) were applied on
both volar forearms of 10 volunteers (a total of 20 sites per treatment).
Fluorescence measurements were acquired before and after application of
salicylic acid, as well as once a day from then on until the ¯uorescence
signal reduced to levels of native skin ¯uorescence.
In a ®nal set of experiments ®ve different dilutions of salicylic acid
solution (corresponding to surface concentrations ranging between 0.5
and 5 mg per cm2) were applied on the volar forearms of nine volunteers.
Fluorescence measurements were acquired before and after application of
salicylic acid. The sites were tape stripped gently once, as described
above. The tapes were placed into a 15 ml Falcon polypropylene tube
(Becton Dickinson Labware, Franklin Lakes, NJ). Methanol (3 ml in
each tube, Burdick & Jackson, Muskegon, MI) was used to extract the
salicylic acid from the tapes. The solutions were sonicated for 30 min
and stored in a refrigerator at < 5°C before HPLC analysis for quanti®-
cation.
Analytical methods The HPLC system was equipped with an
ultraviolet±visible detector and a photodiode array detector, capable of
monitoring absorption at 300 nm, a column oven, and an automatic
sampling system (HP 1100 HPLC). The HPLC column used was a
reverse phase Selectosil C18 column (150 3 3.2 mm internal diameter,
5 mm average particle size; from Phenomenex). The mobile phase
consisted of 70% tetramethylammonium hydroxide solution, 15%
acetonitrile, and 15% methanol. Glacial acetic acid (1 ml) was added to
the mobile phase to improve the separation resolution. The ¯ow rate
was 0.4 ml per min and the column was kept at 40°C. The absorption
was measured at 300 nm. Calibration was done by running standards in
every sample set by linear regression of peak area versus concentration
(standard concentrations 0, 0.5, 1, 5 mg per ml salicylic acid in
methanol). The mean retention time for salicylic acid was 2.8 min and
free from any potential biologic interference. A typical run took less than
7 min. The sample extract was ®ltered through a 0.45 mm PTFE ®lter
(Whatman), discarding the ®rst 1 ml into an autosampler vial. The
duplicates typically agreed within 3% of their average following this
method.
In vivo ¯uorescence spectroscopy was performed using a SPEX
SkinSkan spectro¯uorimeter (SPEX Industries, Edison, NJ). Excitation
radiation from a 125 W xenon arc lamp was ®ltered through an
excitation double monochromator (200±660 nm wavelength range and
1200 grooves per mm grating) and was focused onto one leg of a
bifurcated quartz ®ber optic bundle (Fig 1). The ®ber optic bundle
(2 mm total diameter) consisted of 62 ®bers (214 mm in diameter each)
and was used to deliver excitation radiation to the skin and emission
radiation from the skin back to the spectro¯uorimeter. The excitation
and emission ®bers were randomly dispersed. Measurements were
acquired by placing the ®ber optic probe in contact with the skin
sample. In a subset of experiments a ¯at quartz spacer (1.2 mm thick)
was placed between the ®bers and the skin. In all cases collected
radiation was ®ltered through an emission double monochromator (200±
680 nm wavelength range and 1200 grooves per mm grating) and was
quanti®ed by a photomultiplier (PMT) detector (R1527, Hamamatsu,
Hamamatsu City, Japan). The xenon arc lamp output was measured as
reference at excitation by an ultraviolet (UV) enhanced silicon photo-
Figure 1. Schematic diagram of the experimental setup.
Table I. The ¯uorescence maxima of (i) salicylic acid powder, (ii) skin treated with a formulation including 3% salicylic
acid (formulation A), (iii) skin treated with the same formulation without salicylic acid (formulation B; placebo), and (iv)
untreated skin, as observed at the corresponding ¯uorescence spectraa
Designation Excitation (nm) Emission (nm) Relative intensity (a.u.)
Powder a' 270 370 0.14
b¢ 280 430 0.17
c¢ 350 370 0.28
d¢ 350 430 0.18









d 350 420 0.86
Formulation B on skin e 270 310 0.02
(placebo) f 310 370 0.13
g 360 430 0.21
h 370 460 0.17
Untreated skin i 300 340 0.06
j 340 390 0.04
k 360 430 0.05
l 370 460 0.06
aThe ¯uorescence intensities have been normalized to the maximum one (designated b).
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diode detector. The spectro¯uorimeter was controlled by a computer
using DataMax spectroscopy software based on Grams/32â (Galactic
Industries, Salem, NH). The user was able to control excitation and
emission wavelength for single point measurements or scans, as well as
the high voltage bias of the PMT. Before each set of measurements the
instrument was spectrally calibrated for excitation and emission following
the manufacturer's instructions. Brie¯y, for excitation calibration a
reference scan of the light source was acquired and the absolute
maximum was set to 467 nm (characteristic of the xenon arc source).
For emission calibration a synchronous scan was acquired of a white
diffuse re¯ectance calibration plate (Minolta CR-200/CR-300) and the
absolute maximum of the signal was set to 467 nm. The Minolta plate
has optical properties similar to a barium sulfate surface, but was
preferred over the latter due to its structural integrity. The chromatic
resolution of the spectro¯uorimeter was 61 nm.
Wavelength optimization The optimum excitation±emission pair for
measurements of ¯uorescent compound deposition on skin should be at
a ¯uorescence maximum with minimal background interference and
minimal self-absorption. Interfering signals may arise from either skin
native ¯uorescence (Leffell et al, 1988; Zeng et al, 1995; Kollias et al,
1998; Brancaleon et al, 1999) or ¯uorescence of formulation components
other than salicylic acid. In order to identify the optimum excitation±
emission pair, we acquired the ¯uorescence spectra of the following: (i)
salicylic acid powder; (ii) skin treated with a formulation including 3%
salicylic acid (formulation A); (iii) skin treated with the same formulation
without salicylic acid (formulation B; placebo); and (iv) untreated skin.
The spectra were acquired as a series of 31 emission scans (260±560 nm)
with excitations ranging between 240 nm and 550 nm. Measurements
were recorded every 10 nm. Table I summarizes all local maxima of the
corresponding spectra. The spectrum obtained from salicylic acid powder
is very similar to the one obtained from formulation A with the maxima
only slightly shifted and the relative intensities changed. The ¯uorescence
maxima of salicylic acid in formulation A are 3±42 times stronger than
the signals from other ingredients in the formulation (see maxima of
formulation B). Two of the salicylic acid ¯uorescence maxima
(designated c and d) are overlapping with broad skin auto¯uorescence
maxima (j, k, and l). There is minimal skin auto¯uorescence at the
excitation±emission wavelength pairs of the other two maxima of
salicylic acid (a and b). Finally, of these two we can obtain a better
dynamic range if we use the strongest one (designated b).
Salicylic acid powder absorbance was measured in the UV. A single
narrow band was detected centered at 314 nm with a bandwidth at half
maximum of 16 nm. Absorbance was insigni®cant at 290 nm or 420 nm
(<0.1 absorbance units). We concluded that the wavelength pair of
excitation at 290 nm and emission at 420 nm was the ideal choice for
measuring salicylic acid ¯uorescence, as it resulted in a strong signal with
minimal interference from background (for salicylic acid concentrations
> 0.1 mg per cm2) and insigni®cant self-absorption phenomena. Figure 2
shows the difference in excitation spectra before and after treatment of
volar forearm skin with 10 mg per cm2 salicylic acid.
Optical modeling The following model has been developed to
correct the recorded ¯uorescence signal for variations due to local
differences in the optical properties of the skin, namely absorption
and scattering. For simplicity the model is based on a ®rst-order
approximation of these optical phenomena. We assume that the
compound to be quanti®ed has been deposited in the ®rst few
micrometers (<10 mm) of the stratum corneum and is bound to it
(Fig 3). With the excitation monochromator set at lexc, radiation is
delivered to the skin surface by the excitation ®bers. Due to the
mismatch between the index of refraction of air (nair = 1) and that
of the stratum corneum (nSC » 1.5) (van Gemert et al, 1989), a
fraction of the incident radiation will be returned back as specular
Figure 2. A series of 31 excitation scans on volar forearm skin
before and after treatment with 10 mg per cm2 salicylic acid. (A)
Before treatment; (B) after treatment. The emission wavelength was
increased for every successive scan by 10 nm starting at 260 nm and
®nishing at 560 nm. The two plots are shown in the same scale to
demonstrate the increase of the ¯uorescence signal at 290 nm excitation.
Using this excitation and measuring at 420 nm emission the interference
from skin native ¯uorescence is minimal.
Figure 3. Schematic model of the optical phenomena occurring
when excitation radiation is delivered to skin with a super®cially
deposited ¯uorescent compound.
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re¯ection (Hecht and Zajac, 1979). This fraction can be calculated
from the Fresnel equation for normal incidence of light on the
interface, f = [(nairnSC)/(nair + nSC)]
2 (Jenkins and White, 1976; Hecht
and Zajac, 1979), and is about 4%. The radiation that passes through
the interface (with intensity I1) is absorbed by the molecules of the
¯uorescing compound and causes them to emit radiation at longer
wavelengths (lem). The ¯uorescence is emitted uniformly in all
directions. The intensity of the emitted radiation in the forward
direction (towards the dermis) is I2 = I1F¯, where F¯ is a
proportionality factor depending on the concentration of the
¯uorophore, the quantum yield at lexc, the extinction coef®cient at
lexc, and the geometry of the probe. When lexc = 290 nm the
excitation radiation that is not attenuated by the exogenous
compound is absorbed by the proteins in the stratum corneum, e.g.,
the amino acids tryptophan and tyrosine absorb strongly in the range
280±290 nm (Anglin et al, 1972; Anderson and Parrish, 1981). The
forward part of the emitted radiation travels through the epidermis,
where it is partially absorbed by epidermal chromophores, mainly by
melanin (Anderson and Parrish, 1981; Kollias and Baqer, 1985;
1987). When it reaches the basal layer a fraction of it gets re¯ected
back at the interface and the rest enters the dermis (with intensity
I3 = I2Fa, where Fa is a proportionality factor depending on the
concentration of the absorber and its extinction coef®cient at lem).
In the dermis collagen scatters the entering radiation, whereas
hemoglobin attenuates its intensity (Anderson and Parrish, 1981;
Andersen, 1997) (in the case of lem = 420 nm hemoglobin
attenuation is strong). A signi®cant fraction (Fsc) scatters back to the
epidermis (I4 = I3Fsc), where it is absorbed again partially by melanin
(by a factor of 1 ± Fa) and ®nally reaches the surface of the skin
(I5 = I4Fa), where it is collected by the emission ®bers and measured
by the instrument with the emission monochromator set at lem. The
®ber bundle has a narrow collection angle (6 10°) and therefore
only radiation scattered within this angle could be measured.
Combining the equations together we get
I5  FaI4  FSCFaI3  FSCF2a I2  FflFSCF2a I1 1
By setting the excitation and emission monochromators at the same
wavelength (lexc = lem) we measure the diffuse re¯ectance of the
skin at this wavelength. Assuming that the extinction coef®cient of
the absorbing chromophore is negligible at this wavelength (I2¢ = I1)
then
Figure 4. The relation between corrected ¯uorescence
measurements and surface concentration of salicylic acid for
moderate and low concentrations. (A) Moderate concentration; (B)
low concentration. Data show average values of measurements acquired
from 10 volunteers with skin types ranging from I to IV. Error bars
indicate standard deviations. The solid lines represent the ®tted power
(C = 0.21 3 (F ± 0.09)1.68) and linear (C = 0.53 3 (F ± 0.09)) curves
for moderate and for low concentrations, respectively. Note that the
corrected ¯uorescence value at zero concentration is not zero (0.09 a.u.).
This value corresponds to native skin ¯uorescence.
Figure 5. Excitation spectra using a quartz spacer. (A) The
emission collection angle is being enhanced using a quartz spacer
between the probe and the skin, resulting in a larger emission collection
area. (B) A series of 31 excitation scans on volar forearm skin treated
with 10 mg per cm2 salicylic acid with a quartz spacer placed between
the probe and the skin. The emission wavelength was increased for every
successive scan by 10 nm starting at 260 nm and ®nishing at 560 nm.
298 STAMATAS ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
I05  FaI04  FSCFaI03  FSCF2a I02  FSCF2a I1 2




As we mentioned, F¯ depends only on the concentration of the
¯uorophore and its quantum yield at lexc, and therefore the ratio is
independent of tissue absorption and scattering, as well as ¯uctuations of
excitation radiation intensity. For low concentrations the assumptions of
the Beer±Lambert law are well approximated and the above ratio is
linearly proportional to the ¯uorophore concentration.
Therefore, by normalizing the ¯uorescence signal by the diffuse
re¯ectance at the emission wavelength we can correct for absorption and
scattering phenomena by native skin constituents. After placing the probe
on the site of interest, the intensity of the ¯uorescence emission (at
lex = 290 nm and lem = 420 nm) was recorded, with the high voltage
of the PMT detector kept at 950 V. Then the diffuse re¯ectance value
was recorded at 420 nm at the same site without moving the probe. The
PMT high voltage was reduced to 400 V to avoid detector saturation.
RESULTS
The corrected ¯uorescence intensities in arbitrary units (a.u.)
measured for different surface concentrations of salicylic acid are
shown in Fig 4. In general the calibration curve can be ®tted by a
power law (Rhodes and Diffey, 1997):
C = a(F ± F0)
b (4)
where C is the surface concentration of salicylic acid in mg per cm2,
F is the corrected ¯uorescence intensity at the selected excitation
and emission wavelengths in a.u., F0 is the corrected value of native
skin ¯uorescence, and a and b are parameters to be ®tted. For the
case of salicylic acid and for excitation 290 nm and emission
420 nm we found F0 = 0.09 a.u., a = 0.21 mg per cm2 per a.u.,
and b = 1.68. The detection limit was 0.1 mg per cm2. The
saturation phenomenon determines the upper limit for measure-
ments to be about 20 mg per cm2. The PMT provides a dynamic
range that is greater than the apparent saturation of the signal at
high concentrations. Therefore, this apparent saturation most
probably re¯ects a chemical saturation of the stratum corneum
with salicylic acid. For concentrations below 1 mg per cm2 the
relation between the concentration and the ¯uorescence can be
assumed to be linear (i.e., we approach the limit of the Beer±
Lambert law):
C = a¢ (F ± F0) (5)
where a¢ = 0.53 mg per cm2 per a.u. The average coef®cient of
variation of the ¯uorescence intensity before the correction was
67%. After the correction it was reduced to 19%. The calibration
curves of Fig 4 were validated with samples of known concentra-
tion. The error was calculated to be less than 10% for both low
concentrations and moderate concentrations.
We tested the assumption that salicylic acid is localized mostly in
the top layers of the epidermis ®rst by placing a 1.2 mm thick
quartz ¯at plate between the ®ber probe and the treated skin sites,
thus enhancing the collection angle of the ®ber bundle (Fig 5A),
and second by applying the tape stripping method. Figure 5(B)
shows a series of excitation spectra similar to those of Fig 2 for a
skin site treated with 10 mg per cm2 salicylic acid only this time a
quartz spacer was placed between the probe and the skin. Using this
con®guration we were able to detect ¯uorescence originating
mostly from the super®cial layer of the stratum corneum (Fig 5A).
The maximum ¯uorescence intensity was 25% higher than the
corresponding measurement without the spacer (Fig 2). This
provided the ®rst indication that most of the salicylic acid has been
deposited on the super®cial layer.
Tape stripping of the treated site and measurements of ¯uores-
cence between strips provided more evidence that most of the
¯uorescent source was localized in the ®rst layers of the stratum
corneum. It was found that the ¯uorescence signal decreased
exponentially with the number of tapes (Fig 6). The data points
can be ®tted with the equation
F = 3.47 3 exp( ± 0.14n) (6)
Figure 6. Fluorescence measurements of salicylic acid on skin
following tape stripping. The data show average values of
measurements from four sites on two volunteers. Error bars indicate the
standard error of the mean. The ®tted line is given by F = 3.57 3 exp(±
0.14n).
Figure 7. Salicylic acid concentration on skin decreases
exponentially over time as evidenced by the decrease in
¯uorescence. The squares represent average corrected ¯uorescence
intensity values for an initial surface concentration of 10 mg per cm2 and
the diamonds the corresponding values for an initial surface
concentration of 3 mg per cm2. Error bars indicate the standard error of
the mean. The solid lines represent the ®tted exponential curves given
by F = 9.9 3 exp(±1.4t) and F = 5.1 3 exp(±1.4t), respectively.
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where n is the number of tapes used. Measurements conducted
on untreated sites before and after tape stripping showed that native
¯uorescence with the excitation±emission pair used (290 nm
excitation and 420 nm emission) did not change with tape
stripping. After 10 tape strips the residual salicylic-acid-induced
¯uorescence was < 1% of that before.
The salicylic-acid-induced ¯uorescence was followed daily for
two different concentrations until the ¯uorescence intensity was
reduced to < 5% of the initial signal (Fig 7). The ¯uorescence
intensity decreased exponentially for both initial surface concen-
trations over time with the same rate constant, k = ±1.4 d±1.
Assuming that corneocytes are continuously shed at a constant rate,
the exponential decrease is yet another indication of the exponen-
tial distribution pro®le of salicylic acid in the stratum corneum
layers. Furthermore, these results indicate that salicylic acid may be
used as a marker for exfoliation measurements.
We compared the presented ¯uorescence method with the
commonly used technique of tape stripping followed by extraction
and HPLC analysis. The results for ®ve different concentrations of
salicylic acid are shown in Fig 8. The two methods correlated well
(R2 = 0.967); however, for the same salicylic acid concentrations
the HPLC method resulted in signi®cantly lower values than the
¯uorescence measurements. Furthermore, as evidenced by the error
bars, towards the higher concentrations the HPLC measurements
were more variable than the corresponding ¯uorescence results.
DISCUSSION
In this study, we present a noninvasive spectro¯uorimetric method
for quanti®cation of an exogenous ¯uorophore deposition on skin.
The method would be applicable for the quanti®cation of any
¯uorophore or ¯uorescently labeled compound applied topically
onto the skin. Spectro¯uorimetric measurements present no
limitations due to molecular size or lipophilicity, as does
microdialysis (Benfeldt, 1999). Changes in the molecular environ-
ment of the ¯uorophore, however, can induce changes in its
quantum ef®ciency.
Salicylic acid is ideally suited for quanti®cation on skin because it
excites at a wavelength that is not effective in inducing a strong
native skin ¯uorescence. Second, the excitation radiation is strongly
attenuated by amino acids (tryptophan absorption maximum at
290 nm; Anglin et al, 1972; Anderson and Parrish, 1981), melanin
(absorption increasing to shorter wavelengths in UV; Anderson and
Parrish, 1981), and urocanic acid (absorption maximum at 280 nm;
Hanson and Simon, 1998) and therefore does not penetrate beyond
the ®rst few cell layers of the viable epidermis. Third, the extinction
coef®cient of salicylic acid is relatively small at both the excitation
and the emission wavelengths and therefore correction for inner
®lter effects is not necessary. Finally, the only care that needs to be
taken is to ensure that the blood ¯ow through the measured sites
remains constant during measurement because of the potentially
strong attenuation at the emission wavelength by hemoglobin.
Sweat and sebum are not expected to quench or interfere in any
way with the ¯uorescence of salicylic acid. The ¯uorescence of
salicylic acid was strong whether it was dissolved in aqueous
solutions or in a lipid mixture that resembled the composition of
sebum (data not shown).
The ¯uorescence maxima of salicylic acid deposited on skin
reported in this study are close to the maxima of the compound in
solution. Miles and Schenk (1970) reported that, depending on the
solvent, salicylic acid has a ¯uorescence maximum ranging between
280 nm and 300 nm excitation and around 450 nm emission,
consistent with the wavelengths chosen for this study (290 nm
excitation and 420 nm emission).
When measuring ¯uorescence in vivo, the signal may be
compromised due to radiation absorption by chromophores native
to skin. Melanin in the epidermis and hemoglobin in the dermis are
the primary chromophores that absorb UV and visible radiation.
Their concentration varies between individuals and between
different skin sites. Radiation absorption may occur at the
excitation and/or the emission wavelengths. This is an important
factor to be considered for intrasubject and intersubject consistency
of the ¯uorescence measurements. We have presented a simple
algorithm to account for differences in tissue absorption especially
at the emission wavelength. In the case of super®cially deposited
compounds and for the probe geometry we described, we showed
that correction for absorption by endogenous chromophores at the
emission wavelength is most important. To this end we normalized
the measured ¯uorescence intensity by the diffuse re¯ectance of
radiation at the emission wavelength. We demonstrated experi-
mentally that the ratio of ¯uorescence to diffuse re¯ectance is
independent of the concentration of absorbing chromophores for
Fitzpatrick skin types I±III, as the average coef®cient of variation
for measurements between subjects was signi®cantly decreased after
the correction (from 67% before correction to 19% after correc-
tion).
Investigators studying native skin ¯uorescence have proposed
normalization of the ¯uorescence signal using diffuse re¯ectance
(Wu et al, 1993; Zeng et al, 1995). This suggestion has been based
on theoretical analysis of photon migration using diffusion
approximation theory and Monte Carlo simulations. In this study
we reached the same conclusion for the measurement of ¯uores-
cence signals from compounds applied externally to skin. Another
method that accounts for phenomena such as photon reabsorption
and scattering is using partial least squares analysis to develop an
empirical linear model for ¯uorescence from a turbid medium such
as skin (Durkin and Richards-Kortum, 1996). This method
requires a substantial training set of measurements from a tissue
phantom with optical properties similar to skin, however.
Using the corrected ¯uorescence, we demonstrate that for low
concentrations of salicylic acid (up to 1 mg per cm2) the ¯uores-
cence signal varies linearly with concentration, whereas for
moderate concentrations its ¯uorescence can be modeled as a
simple exponential (for concentrations up to 20 mg per cm2). The
detection limit of this method (0.1 mg per cm2) was better than that
reported for tape stripping followed by extraction and HPLC
analysis (1 mg per cm2) (Pirola et al, 1998). Comparison of the two
techniques (Fig 8) showed that the chromatographic method
underestimates the salicylic acid concentrations. This can be
Figure 8. Comparison of the ¯uorescence method of quantifying
salicylic acid on skin with the traditional method of tape
stripping followed by HPLC. The data show average values from
samples from nine volunteers. Error bars indicate the standard error of
the mean. The ®tted line is given by CHPLC = 0.325 3 CFluorescence
with R2 = 0.967.
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explained by the incomplete removal of all the salicylic acid from
the stratum corneum by tape stripping and liquid extraction.
Furthermore, the greater variability in the HPLC results possibly
arises from the increased probability of experimental error due to
the many steps of the procedure (tape stripping, extraction, HPLC
analysis) compared to the single step of the ¯uorescence method.
We demonstrated that most of the salicylic acid is deposited on
the ®rst few layers of the stratum corneum. Hence, our method
may be useful for evaluating skin desquamation rates, keeping in
mind that salicylic acid itself is a keratolytic agent at concentrations
higher than 2%, which corresponds to > 10 mg per cm2 surface
concentration (Huber and Christophers, 1977; Roberts et al, 1980;
Loden et al, 1995; Kligman and Kligman, 1998). The currently used
methods to evaluate desquamation rates include cohesography
(Marks et al, 1977), surfometry (Marks et al, 1977), disappearance of
dansyl chloride ¯uorescence staining (Roberts and Marks, 1980),
silver nitrate staining (Roberts and Marks, 1980; Roberts et al,
1980), and quanti®cation of the stratum corneum material removed
by tape stripping (Loden et al, 1995). The use of salicylic acid
¯uorescence to this end provides a nondestructive, noninvasive,
and nontoxic alternative.
Our observation that after topical application the salicylic acid
concentration decreases exponentially with skin depth is in
agreement with microdialysis studies (Benfeldt and Serup, 1999).
Similar concentration pro®les have been reported before for other
molecules and have been attributed to the larger spaces in the upper
laminae of the stratum corneum rather than to small diffusion
coef®cients of the deposited molecules (Tregear, 1966). The
stratum corneum has been reported to act as a reservoir for salicylic
acid delivery (Rougier et al, 1985). Penetration of salicylic acid is
measurable only when the stratum corneum is perturbed by tape
stripping or delipidation (Birmingham et al, 1979; Benfeldt, 1999).
Otherwise, most of the deposited compound remains bound on the
stratum corneum (Neubert et al, 1990; Bommannan et al, 1992;
Loden et al, 1995; Wester et al, 1998) until it gets removed due to
natural skin turnover. This fact was demonstrated by the
exponential decrease of ¯uorescence over a period of a few days.
The lag time for measurable salicylic acid penetration in full
thickness human skin is about 20 h and for epidermis alone about
9 h at pH 4 (Harada et al, 1993), times well above the time it takes
for the ¯uorescence measurement.
Although in our experiments we have used a compound that is
deposited on the stratum corneum, the spectro¯uorimetric method
presented here can also be applied for the quantitation of
compounds that penetrate the epidermal layers. In the latter case,
however, it is more dif®cult to get information about the
localization of the ¯uorescent compound in the skin in vivo and
noninvasively. Measurement of the penetration of the excitation
wavelength may provide some information on the localization of
the compound. The time dependence of the ¯uorescence signal
may also give information about the penetration of the compound
through skin. If the wavelengths are suitable in vivo ¯uorescence
confocal microscopy (Bussau et al, 1998) may be useful. Otherwise
one has to rely on more invasive methods, namely histologic
evaluations.
In conclusion, we have demonstrated that ¯uorescence spec-
troscopy can be used to quantify the accumulation of a ¯uorescent
compound on a biologic tissue in vivo. The limitation is that
interference from native skin ¯uorescence should be minimal at the
wavelengths of interest. As an example we measured salicylic acid
deposited on skin. The major advantages of this method are: (i) it is
sensitive (low detection limit); (ii) it is noninvasive; (iii) it shows
good reproducibility; and (iv) it is fast and simple to implement
compared to the methods available to date.
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